País: Regne Unit
Idioma: anglès
Font: VMD (Veterinary Medicines Directorate)
Chlamydophila felis, Feline calicivirus, Feline viral rhinotracheitis virus
Intervet UK Ltd
Chlamydophila felis, Feline calicivirus, Feline viral rhinotracheitis virus
Expired
Revised: July 2012 AN: 01875/2011 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobivac Ducat-Chlam 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per dose of 1 ml reconstituted vaccine: ACTIVE SUBSTANCES: live attenuated feline calicivirus, strain F9: 10 4.6 — 10 6.4 PFU* live attenuated feline herpes virus type 1, strain G2620A: 10 5.2 – 10 7.0 0 PFU live attenuated _Chlamydophila felis_, strain Baker: 10 2.3 – 10 4.0 CCID 50. ** * Plaque-Forming Units ** Cell culture infective dose 50% EXCIPIENT(S): For a full list of excipients, see section 6.1. SOLVENT: Phosphate buffered saline. 3. PHARMACEUTICAL FORM Lyophilisate and solvent for suspension for injection. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cat 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Active immunisation of cats: - to reduce the clinical signs caused by infection with feline calicivirus and feline herpes virus type 1, - to reduce the severity of the clinical signs caused by infection with _Chlamydophila _ _felis_, Onset of immunity: for FCV and FHV: 4 weeks; for _Chl. felis_: 3 weeks. Duration of immunity for FCV, FHV, _Chl. felis_: 1 year. 4.3 CONTRAINDICATIONS See 4.7. 4.4 SPECIAL WARNINGS Because antimicrobials may inactivate the live _Chl. felis_ vaccine strain, systemic antimicrobial therapy should be avoided during vaccination and for a two week period afterwards. Maternal antibodies, which may persist up to the age of 9-12 weeks, can have a negative influence on the efficacy of vaccination. In the presence of maternal antibodies, vaccination may reduce the protection against a _Chl. felis_ infection. In such cases where a high level of maternally derived antibodies is expected, the vaccination schedule should be planned accordingly. Page 1 of 4 R Llegiu el document complet